[HTML][HTML] COVID-induced thyroid autoimmunity
A Brancatella, N Viola, F Santini, F Latrofa - Best Practice & Research …, 2023 - Elsevier
Breakdown of self-tolerance to thyroid antigens (thyroperoxidase, thyroglobulin and the
thyrotropin-receptor) is the driver of thyroid autoimmunity. It has been suggested that …
thyrotropin-receptor) is the driver of thyroid autoimmunity. It has been suggested that …
Thrombosis and Anticoagulation Strategies in Patients with COVID-19 Including Japanese Perspective
Y Yamashita, T Kobayashi, M Mo - Journal of Atherosclerosis and …, 2023 - jstage.jst.go.jp
Abstract Coronavirus disease 2019 (COVID-19) has become a major health problem
worldwide since 2020. Although the main pathophysiology of COVID-19 is a respiratory …
worldwide since 2020. Although the main pathophysiology of COVID-19 is a respiratory …
[引用][C] Şiddetli hastalık bulgusu olan COVID-19 tanılı hastalardaki klinik, laboratuvar ve radyolojik bulgularının mortalite üzerine etkisi
SM Çolak, T İlgar, S Koç, K Akyüz, G Çakır Odabaş… - 2023 - acikerisim.erdogan.edu.tr
Giriş: COVID-19 asemptomatik hastalıktan kritik hastalığa kadar değişebilen şekilde
seyredebilen ve mortalite ile sonuçlanabilen bir hastalıktır. Çalışmamızda COVID-19 tanısı …
seyredebilen ve mortalite ile sonuçlanabilen bir hastalıktır. Çalışmamızda COVID-19 tanısı …
新型コロナウイルス感染症に対する静脈血栓塞栓症予防対策
輕部義久， 孟真， 根本寛子， 伏見謙一， 阿賀健一郎… - 静脈学, 2024 - jstage.jst.go.jp
抄録 新型コロナウイルス感染症 (COVID-19) における静脈血栓塞栓症 (VTE)
を主とした血栓症対策として, 当院入院 94 例に 「新型コロナウイルス感染症 (COVID-19) …
を主とした血栓症対策として, 当院入院 94 例に 「新型コロナウイルス感染症 (COVID-19) …